| 1 | RARRES1
|
| Autocrine and paracrine effects of a novel podocyte gene, RARRES1
|
| Chen A, Lee K, He JC.
|
| Kidney Int. Oct;100(4):745-747. doi: 10.1016/j.kint.2021.07.008 2021
|
| 2 | RARRES1
|
| Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression
|
| Chen A, Feng Y, Lai H, Ju W, Li Z, Li Y, Wang A, Hong Q, Zhong F, Wei C, Fu J, Guan T, Liu B, Kretzler M, Lee K, He JC.
|
| J Clin Invest. Oct 1;130(10):5523-5535. doi: 10.1172/JCI140155. 2020
|
| 3 | RARRES1, SPINK2
|
| Tazarotene-Induced Gene 1 (TIG1) Interacts with Serine Protease Inhibitor Kazal-Type 2 (SPINK2) to Inhibit Cellular Invasion of Testicular Carcinoma Cells
|
| Shyu RY, Wang CH, Wu CC, Wang LK, Chen ML, Kuo CY, Lee MC, Lin YY, Tsai FM.
|
| Biomed Res Int. Nov 25;2019:6171065. doi: 10.1155/2019/6171065. 2019
|
| 4 | RARRES1
|
| Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells
|
| Maimouni S, Issa N, Cheng S, Ouaari C, Cheema A, Kumar D, Byers S.
|
| PLoS One Dec 17;13(12):e0208756. doi: 10.1371/journal.pone.0208756. 2018
|
| 5 | LXN, RARRES1
|
| Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN. 2013 PMID:
|
| Oldridge EE, Walker HF, Stower MJ, Simms MS, Mann VM, Collins AT, Pellacani D, Maitland NJ.
|
| Oncogenesis Apr 15;2(4):e45. doi: 10.1038/oncsis.2013.6. 2013
|
| 6 | RARRES1
|
| Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding
|
| Peng Z, Shen R, Li YW, Teng KY, Shapiro CL, Lin HJ.
|
| PLoS One. ;7(5):e36891. doi: 10.1371/journal.pone.0036891. Epub 2012 May 17 2012
|
| 7 | AGBL2, KIF11, RARRES1
|
| Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle.
|
| Sahab ZJ, Hall MD, Me Sung Y, Dakshanamurthy S, Ji Y, Kumar D, Byers SW.
|
| Cancer Res 71(4):1219-28. Epub 2011 Feb 8.
2011
|
| 8 | GRK5, RARRES1
|
| G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells.
|
| Wu CC, Tsai FM, Shyu RY, Tsai YM, Wang CH, Jiang SY.
|
| BMC Cancer 11:175.
2011
|
| 9 | RARRES1
|
| Expression and mutation analysis of TIG1 (tazarotene-induced gene 1) in human gastric cancer.
|
| Son MS, Kang MJ, Park HC, Chi SG, Kim YH.
|
| Oncol Res 17(11-12):571-80.
2009
|
| 10 | RARRES1
|
| Role of the RARRES1 gene in nasopharyngeal carcinoma.
|
| Kwok WK, Pang JC, Lo KW, Ng HK.
|
| Cancer Genet Cytogenet 194(1):58-64.
2009
|
| 11 | RARRES1
|
| Involvement of tazarotene-induced gene 1 in proliferation and differentiation of human adipose tissue-derived mesenchymal stem cells.
|
| Ohnishi S, Okabe K, Obata H, Otani K, Ishikane S, Ogino H, Kitamura S, Nagaya N.
|
| Cell Prolif 42(3):309-16. Epub 2009 Feb 24.
2009
|
| 12 | RARRES1
|
| RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma.
|
| Wu CC, Shyu RY, Chou JM, Jao SW, Chao PC, Kang JC, Wu ST, Huang SL, Jiang SY.
|
| Eur J Cancer 42(4):557-65. Epub 2006 Jan 19. 2006
|
| 13 | RARRES1, RARRES3
|
| Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
|
| Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP.
|
| Int J Cancer 113(3):386-92. 2005
|
| 14 | RARRES1
|
| DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
|
| Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W.
|
| Cancer 104(8):1609-19. 2005
|
| 15 | RARRES1, RARRES2
|
| Molecular mechanisms of tazarotene action in psoriasis.
|
| Duvic M, Nagpal S, Asano AT, Chandraratna RA.
|
| J Am Acad Dermatol 37(2 Pt 3):S18-24. Review. 1997
|
| 16 | RARRES1
|
| Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive genein skin.
|
| Nagpal S, Patel S, Asano AT, Johnson AT, Duvic M, Chandraratna RA.
|
| J Invest Dermatol 106(2):269-74. 1996
|